Viracta Therapeutics Inc (VIRX)
0.0240 -0.0012 (-4.76%) 14:34 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | VIRX | VXF | |||
| Company | Viracta Therapeutics Inc | Extended Market Index ETF Vanguard | |||
| Price Information | |||||
| Exchange | OTC US | NYSE Arca | |||
| Open | 0.0250 | 176.26 | |||
| High | 0.0288 | 176.69 | |||
| Low | 0.0229 | 172.00 | |||
| Last | 0.0240 | 172.69 | |||
| Change | -0.0012 | -3.95 | |||
| % Change | -4.76% | -2.24% | |||
| Volume | 93,564 | 245,441 | |||
| 20-Day Average Volume | 220,480 | 624,290 | |||
| Previous Close | 0.0252 | 176.64 | |||
| Industry | Medical - Drugs | N/A | |||
| Has Options | Yes | Yes | |||
| Technicals | |||||
| 20-Day Moving Average | 0.0268 | 177.34 | |||
| 20-Day Raw Stochastic | 5.80% | 15.83% | |||
| 20-Day Relative Strength | 38.67% | 37.43% | |||
| Weighted Alpha | -86.44 | -3.85 | |||
| Today's Opinion | 100% Sell | 56% Sell | |||
| Previous Opinion | 100% Sell | 56% Sell | |||
| Last Month's Opinion | 100% Sell | 24% Buy | |||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.40% since 03/21/25 | -2.62% since 03/21/25 | |||
| Low | 0.0229 on 03/28/25 | 172.00 on 03/28/25 | |||
| High | 0.0300 on 03/25/25 | 182.47 on 03/24/25 | |||
| 1-Month | |||||
| %Chg | +0.44% since 02/28/25 | -8.13% since 02/28/25 | |||
| Low | 0.0200 on 03/12/25 | 169.37 on 03/13/25 | |||
| High | 0.0700 on 03/07/25 | 189.55 on 03/03/25 | |||
| 3-Month | |||||
| %Chg | -85.69% since 12/27/24 | -10.17% since 12/27/24 | |||
| Low | 0.0080 on 02/11/25 | 169.37 on 03/13/25 | |||
| High | 0.2389 on 01/06/25 | 202.35 on 01/31/25 | |||
| 6-Month | |||||
| %Chg | -89.68% since 09/27/24 | -5.07% since 09/27/24 | |||
| Low | 0.0080 on 02/11/25 | 169.37 on 03/13/25 | |||
| High | 0.2972 on 10/25/24 | 207.77 on 11/25/24 | |||
| Key Statistics | |||||
| Market Capitalization, $K | 1,002 | 20,247,171 | |||
| Shares Outstanding, K | 39,744 | 114,513 | |||
| Annual Sales | 0 | 0 | |||
| Annual Net Income | -51,060,000 | 0 | |||
| Last Quarter Sales | 0 | N/A | |||
| Last Quarter Net Income | -10,550,000 | N/A | |||
| 60-Month Beta | 1.44 | 1.19 | |||
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/13/24 | N/A | |||
| Latest Earnings Date | 04/03/25 | N/A | |||
| Most Recent Dividend | N/A | 0.613 on 03/25/25 | |||
| Next Ex-Dividends Date | N/A | 03/25/25 | |||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.20 | |||